title: [Route and preparation of 5-Fu administration as preoperative adjuvant chemotherapy in rectal cancer. II. Morphologic, ultrastructural and histochemical changes of the cancer cells after intrarectal and intravenous 5-Fu administration].
abstract: From March 1981 to October 1985, 5-Fu was preoperatively given to 65 Dukes B and C rectal cancer patients (intrarectal suppository 40 and emulsion 20, intravenous 5). The results indicated that after intrarectal administration, marked changes and destruction of the cancer cells in morphology were observed in 40% of the resected rectal specimens for suppository and in 45% for emulsion; marked retrograde degeneration in ultrastructure was found in 47.5% for suppository and in 50% for emulsion; DNA synthesis was obviously reduced in 63% for suppository and in 75% for emulsion. It is suggested that the emulsion be a better preparation. No obvious changes or destruction in morphology and ultrastructure were observed in cancer cells treated by intravenous drip of high dose 5-Fu though leukopenia below 4000 was found in 2/5. However, it was 0/60 by rectal administration. This implies that the intrarectal route is more rational than the conventional intravenous route. This study presents an alternate supplementary treatment in addition to radiotherapy for the reduction of postoperative local recurrence of Dukes B and C rectal cancers.
authors.affiliation: Ruijin Hospital, Shanghai Second Medical College.
authors.forename: X G
authors.initials: XG
authors.lastname: Zhou
authors.forename: Y C
authors.initials: YC
authors.lastname: Wang
authors.forename: B M
authors.initials: BM
authors.lastname: Yu
authors.forename: Y X
authors.initials: YX
authors.lastname: Shen
authors.forename: Z R
authors.initials: ZR
authors.lastname: Chen
authors.forename: L H
authors.initials: LH
authors.lastname: Lin
authors.forename: J S
authors.initials: JS
authors.lastname: Yang
authors.forename: D S
authors.initials: DS
authors.lastname: Zhang
authors.forename: Q G
authors.initials: QG
authors.lastname: Ding
authors.forename: L
authors.initials: L
authors.lastname: Ma
mesh_terms: D000285:Administration, Rectal; D004273:DNA, Neoplasm / Q000096:biosynthesis; D004655:Emulsions; D005472:Fluorouracil / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D011292:Premedication; D012004:Rectal Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000648:ultrastructure; D013488:Suppositories
chemical_list: D004273:DNA, Neoplasm; D004655:Emulsions; D013488:Suppositories; D005472:Fluorouracil